scPharmaceuticals Inc. 2SX.F Stock
scPharmaceuticals Inc. Price Chart
scPharmaceuticals Inc. 2SX.F Financial and Trading Overview
| scPharmaceuticals Inc. stock price | 3.8 EUR |
| Previous Close | 9.65 EUR |
| Open | 9.7 EUR |
| Bid | 9.8 EUR x 0 |
| Ask | 10 EUR x 0 |
| Day's Range | 9.7 - 9.7 EUR |
| 52 Week Range | 4.08 - 11.2 EUR |
| Volume | 30 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 346.96M EUR |
| Beta (5Y Monthly) | 0.194718 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.4 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.67 EUR |
2SX.F Valuation Measures
| Enterprise Value | 265.49M EUR |
| Trailing P/E | N/A |
| Forward P/E | -6.217949 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 168.18239 |
| Price/Book (mrq) | 4.577631 |
| Enterprise Value/Revenue | 128.691 |
| Enterprise Value/EBITDA | -6.566 |
Trading Information
scPharmaceuticals Inc. Stock Price History
| Beta (5Y Monthly) | 0.194718 |
| 52-Week Change | 137.08% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 11.2 EUR |
| 52 Week Low | 4.08 EUR |
| 50-Day Moving Average | 9.32 EUR |
| 200-Day Moving Average | 6.84 EUR |
2SX.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 35.77M |
| Float | 19.29M |
| Short Ratio | N/A |
| % Held by Insiders | 6.51% |
| % Held by Institutions | 69.08% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1961.75% |
| Gross Margin | 70.67% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -25.77% |
| Return on Equity (ttm) | -64.40% |
Income Statement
| Revenue (ttm) | 2.06M EUR |
| Revenue Per Share (ttm) | 0.07 EUR |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -40437000 EUR |
| Net Income Avi to Common (ttm) | -40317000 EUR |
| Diluted EPS (ttm) | -1.36 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 117.36M EUR |
| Total Cash Per Share (mrq) | 3.28 EUR |
| Total Debt (mrq) | 37.68M EUR |
| Total Debt/Equity (mrq) | 49.7 EUR |
| Current Ratio (mrq) | 16.376 |
| Book Value Per Share (mrq) | 2.119 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -43702000 EUR |
| Levered Free Cash Flow (ttm) | -27801000 EUR |
Profile of scPharmaceuticals Inc.
| Country | Germany |
| State | MA |
| City | Burlington |
| Address | 2400 District Avenue |
| ZIP | 01803 |
| Phone | 617 517 0730 |
| Website | https://www.scpharmaceuticals.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 96 |
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. The company was incorporated in 2013 and is headquartered in Burlington, Massachusetts.
Q&A For scPharmaceuticals Inc. Stock
What is a current 2SX.F stock price?
scPharmaceuticals Inc. 2SX.F stock price today per share is 3.8 EUR.
How to purchase scPharmaceuticals Inc. stock?
You can buy 2SX.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for scPharmaceuticals Inc.?
The stock symbol or ticker of scPharmaceuticals Inc. is 2SX.F.
Which industry does the scPharmaceuticals Inc. company belong to?
The scPharmaceuticals Inc. industry is Biotechnology.
How many shares does scPharmaceuticals Inc. have in circulation?
The max supply of scPharmaceuticals Inc. shares is 36.05M.
What is scPharmaceuticals Inc. Price to Earnings Ratio (PE Ratio)?
scPharmaceuticals Inc. PE Ratio is now.
What was scPharmaceuticals Inc. earnings per share over the trailing 12 months (TTM)?
scPharmaceuticals Inc. EPS is -1.4 EUR over the trailing 12 months.
Which sector does the scPharmaceuticals Inc. company belong to?
The scPharmaceuticals Inc. sector is Healthcare.